These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19225205)

  • 1. Intermediate fixed coronary artery stenosis at the site of ergonovine-provoked spasm as a predictor of long-term major adverse cardiac events of patients with coronary spastic angina.
    Nishizawa S; Shiraishi J; Torii S; Miyagawa K; Arihara M; Hadase M; Hyogo M; Yagi T; Shima T; Kohno Y; Matsubara H
    Circ J; 2009 Apr; 73(4):699-704. PubMed ID: 19225205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis.
    Kim DW; Her SH; Ahn Y; Shin DI; Han SH; Kim DS; Choi DJ; Kwon HM; Gwon HC; Jo SH; Rha SW; Baek SH
    Int J Cardiol; 2018 Feb; 252():6-12. PubMed ID: 29249438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation Test.
    Shin DI; Baek SH; Her SH; Han SH; Ahn Y; Park KH; Kim DS; Yang TH; Choi DJ; Suh JW; Kwon HM; Lee BK; Gwon HC; Rha SW; Jo SH
    JACC Cardiovasc Interv; 2015 Jun; 8(7):914-23. PubMed ID: 26003026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine-Provoked Coronary Spasm at Site of Significant Organic Stenosis Predicts Poor Prognosis in Patients With Coronary Vasospastic Angina.
    Ishii M; Kaikita K; Sato K; Tanaka T; Sugamura K; Sakamoto K; Izumiya Y; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Soejima H; Hokimoto S; Matsui K; Ogawa H
    J Am Coll Cardiol; 2015 Sep; 66(10):1105-15. PubMed ID: 26337988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.
    Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
    Coron Artery Dis; 2003 Sep; 14(6):451-7. PubMed ID: 12966266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use.
    Sueda S; Fujimoto K; Sasaki Y; Sakaue T; Yoshii T; Habara H; Kohno H
    Heart Vessels; 2019 May; 34(5):745-754. PubMed ID: 30474702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coronary arterial spasm and symptomatology in ischemic and non-ischemic heart diseases: study of the ergonovine maleate provocative test in 3,000 consecutive patients].
    Nosaka H; Nobuyoshi M
    J Cardiogr Suppl; 1987; 12():35-47. PubMed ID: 3429929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysis.
    Lim AY; Park TK; Cho SW; Oh MS; Lee da H; Seong CS; Gwag HB; Yang JH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Ahn J; Carriere KC; Choi SH
    Int J Cardiol; 2016 Oct; 221():161-6. PubMed ID: 27400315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased basal tone and hyperresponsiveness to acetylcholine and ergonovine in spasm related coronary arteries in patients with variant angina--basal coronary artery tone in patients with variant angina.
    Park SJ; Park SW; Kim JJ; Song JK; Hong MK; Kang DH; Cheong SS; Lee CW; Lee JK
    J Korean Med Sci; 1996 Feb; 11(1):17-25. PubMed ID: 8703366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased basal tone and hyperresponsiveness to acetylcholine and ergonovine in spasm-related coronary arteries in patients with variant angina.
    Lee SJ; Park SJ; Park SW; Kim JJ; Song JK; Hong MK; Kang DH; Cheong SS
    Int J Cardiol; 1996 Jul; 55(2):117-26. PubMed ID: 8842780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events.
    Sueda S
    Heart Vessels; 2020 Oct; 35(10):1368-1377. PubMed ID: 32350639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine.
    Sueda S; Ochi T; Yano K; Mineoi K; Kondou T; Ochi N; Hayashi Y; Kukita H; Matsuda S; Kawada H; Tsuruoka T; Uraoka T
    Jpn Circ J; 2000 Aug; 64(8):559-65. PubMed ID: 10952150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac events in vasospastic angina: site and morphology of coronary artery spasm is related to the long-term prognosis of vasospastic angina].
    Mori F; Uchida T; Byun T; Tanino S; Imamura K; Oomori H; Nagashima M; Enta K; Tanaka M; Kasahara S; Hirosawa K
    J Cardiol; 1999 Apr; 33(4):191-9. PubMed ID: 10225201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.
    Io K; Minatoguchi S; Nishigaki K; Ojio S; Tanaka T; Segawa T; Matsuo H; Watanabe S; Hattori A; Ueno K; Ono H; Hiei K; Sato H; Morita N; Noda T; Kato T; Kawasaki M; Takemura G; Fujiwara H
    Arzneimittelforschung; 2007; 57(9):573-81. PubMed ID: 17966756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical characteristics and prognosis in Taiwanese patients with coronary vasospastic angina pectoris without significant fixed coronary artery disease versus patients with significant fixed coronary artery disease and either stable angina pectoris or acute coronary syndromes.
    Hung MJ; Hung MY; Cheng CW; Yang NI; Cherng WJ
    Am J Med Sci; 2007 Sep; 334(3):160-7. PubMed ID: 17873528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized spasm of the right coronary artery after successful stent implantation provoked by intracoronary administration of ergonovine.
    Li Y; Honye J; Takayama T; Saito S
    Int J Cardiol; 2007 Jul; 119(2):251-4. PubMed ID: 17064794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pharmacological spasm provocation test in patients with a history of syncope.
    Sueda S; Kohno H
    Heart Vessels; 2018 Feb; 33(2):126-133. PubMed ID: 28905210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ergonovine test in angina with normal coronary arteries. Is it worth doing it?
    Coma-Canella I; Castano S; Macías A; Calabuig J; Artaiz M
    Int J Cardiol; 2006 Feb; 107(2):200-6. PubMed ID: 16412797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long lasting spasticity in controlled vasospastic angina.
    Ueda O; Kohchi K; Kishi Y; Numano F
    Heart; 1999 May; 81(5):528-32. PubMed ID: 10212173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics in patients with rest angina and hypoplastic right coronary artery.
    Sueda S; Kohno H
    Heart Vessels; 2020 Apr; 35(4):443-450. PubMed ID: 31529177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.